Clonal haematopoiesis and risk of chronic liver disease

Area of Science:

• Hematology
• Hepatology
• Genetics

Background:

• Chronic liver disease is a significant global health issue.
• Disease progression involves liver inflammation, injury, and fibrosis.
• Clonal hematopoiesis of indeterminate potential (CHIP) is an emerging risk factor.

Purpose of the Study:

• To investigate the association between CHIP and chronic liver disease.
• To explore the underlying mechanisms linking CHIP to liver pathology.

Main Methods:

• Analysis of whole-exome sequencing data from 214,563 individuals across four cohorts.
• Magnetic resonance imaging to assess liver inflammation and fibrosis.
• Mendelian randomization and a mouse model of non-alcoholic steatohepatitis (using Tet2-deficient hematopoietic cells).

Main Results:

• CHIP was associated with increased risk of prevalent and incident chronic liver disease (OR=2.01).
• Individuals with CHIP showed higher likelihood of liver inflammation and fibrosis (OR=1.74).
• Genetic predisposition to CHIP correlated with higher chronic liver disease risk (OR=2.37); Tet2-deficient mice exhibited exacerbated liver inflammation and fibrosis mediated by NLRP3 inflammasome.

Conclusions:

• CHIP is a significant risk factor for chronic liver disease.
• Aberrant inflammatory responses, mediated by the NLRP3 inflammasome, are key mechanisms.
• Findings highlight CHIP as a potential target for preventing liver disease progression.